CSIMarket
 


Generex Biotechnology Corp  (GNBT)
Other Ticker:  
 

Generex Biotechnology's Tangible Leverage Ratio

GNBT's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth


In III Quarter 2021 Generex Biotechnology had stockholder deficit.

Within Major Pharmaceutical Preparations industry Generex Biotechnology Corp achieved the lowest Tangible Leverage Ratio in the third quarter 2021. While total ranking remained the same in the third quarter 2021 compared to the previous quarter at no. .

Explain Tangible Leverage Ratio?
What is GNBT Market Share?
What are GNBT´s Total Liabilities?


GNBT Tangible Leverage Ratio (Apr 30 2021)
III. Quarter
(Jan 31 2021)
II. Quarter
(Oct 31 2020)
I. Quarter
(Jul 31 2020)
IV. Quarter
(Apr 30 2020)
III. Quarter
Y / Y Tangible Equity Change - - - - -
Y / Y Total Liabilities Change 42.17 % 66.23 % 69.62 % 30.74 % -36.87 %
Tangible Leverage Ratio MRQ - - - - -
GNBT's Total Ranking # # # # #
Seq. Tangible Equity Change - - - - -
Seq. Total Liabilities Change -11.3 % 27.07 % 44.09 % -12.46 % 3.71 %



Tangible Leverage Ratio third quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Tangible Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Generex Biotechnology's Tangible Equity $ -91 Millions Visit GNBT's Balance sheet
Generex Biotechnology's Total Liabilities $ 94 Millions Visit GNBT's Balance sheet
Source of GNBT's Sales Visit GNBT's Sales by Geography


Cumulative Generex Biotechnology's Tangible Leverage Ratio

GNBT's Tangible Leverage Ratio for the trailling 12 Months

GNBT Tangible Leverage Ratio

(Apr 30 2021)
III. Quarter
(Jan 31 2021)
II. Quarter
(Oct 31 2020)
I. Quarter
(Jul 31 2020)
IV. Quarter
(Apr 30 2020)
III. Quarter
Y / Y Tangible Equity TTM Growth - - - - -
Y / Y Total Liabilities TTM Growth 42.17 % 66.23 % 69.62 % 30.74 % -36.87 %
Tangible Leverage Ratio TTM - - - - -
Total Ranking TTM
Seq. Tangible Equity TTM Growth - - - - -
Seq. Total Liabilities TTM Growth -11.3 % 27.07 % 44.09 % -12.46 % 3.71 %


On the trailing twelve months basis During the 12 months period ending III Quarter 2021 company had stockholder deficit.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry GNBT recorded the lowest Tangible Leverage Ratio. While total ranking remained unchanged compared to previous 12 month period at no. 0.

Explain Tangible Leverage Ratio?
What is GNBT Market Share?
What are GNBT´s Total Liabilities?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Within the Market #


trailing twelve months Tangible Leverage Ratio Statistics
High Average Low
0 0 0
 




Companies with similar Tangible Leverage Ratio in the quarter ending Apr 30 2021, within Major Pharmaceutical Preparations Industry Tangible Leverage RatioApr 30 2021 MRQ Total LiabilitiesApr 30 2021 MRQ Tangible Equity

Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com